C07D 311/76
Benzo[c]pyrans
C07D311/76 (Benzo[c]pyrans) appears on 214 US grants and 156 published applications in this corpus.
Search patents in C07D- Granted patents
- 214
- Published applications
- 156
- Assignees
- 142
- Inventors
- 725
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 9 | 0 |
| 1981 | 2 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 6 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 9 | 0 |
| 1998 | 4 | 0 |
| 1999 | 9 | 0 |
| 2000 | 3 | 0 |
| 2001 | 7 | 0 |
| 2002 | 8 | 14 |
| 2003 | 12 | 6 |
| 2004 | 2 | 12 |
| 2005 | 4 | 11 |
| 2006 | 1 | 6 |
| 2007 | 1 | 6 |
| 2008 | 7 | 4 |
| 2009 | 7 | 7 |
| 2010 | 1 | 5 |
| 2011 | 2 | 1 |
| 2012 | 3 | 2 |
| 2013 | 2 | 5 |
| 2014 | 2 | 1 |
| 2015 | 5 | 7 |
| 2016 | 5 | 3 |
| 2017 | 3 | 10 |
| 2018 | 3 | 7 |
| 2019 | 8 | 11 |
| 2020 | 9 | 7 |
| 2021 | 9 | 2 |
| 2022 | 1 | 6 |
| 2023 | 2 | 5 |
| 2024 | 1 | 4 |
| 2025 | 3 | 9 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound as PPAR agonist and application thereof10 Feb 2026US 12,545,653 B2USA Elixiria Biotech Inc.
- Compositions comprising a retinoid X receptor (RXR) agonist, a retinoic acid receptor (RAR) agonist, or a dual RXR/RAR agonist3 Feb 2026US 12,540,121 B2Arizona Board of Regents on behalf of Arizona State University
- Nebivolol synthesis method and intermediate compound thereof11 Nov 2025US 12,466,802 B2Zhejiang Ausun Pharmaceutical Co., Ltd.
- Isochroman compound7 Oct 2025US 12,435,101 B2Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
- Compounds and methods for treating fibrotic pathologies1 Apr 2025US 12,264,163 B2Mayo Foundation for Medical Education and Research
- A pharmaceutical composition targeting mutant p53 and her26 Aug 2026US 2026/0224524 A1
- Compounds for the treatment of a central nervous system disease or disorder16 Jul 2026US 2026/0200886 A1
- Compositions Comprising a Retinoid X Receptor (RXR) Agonist, a Retinoic Acid Receptor (RAR) Agonist, or a Dual RXR/RAR Agonist16 Apr 2026US 2026/0103445 A1Arizona Board of Regents on behalf of Arizona State University
- Fto inhibitors5 Feb 2026US 2026/0035341 A1Rpxds Co., Ltd
- Compounds and compositions and uses thereof5 Feb 2026US 2026/0035381 A1PGI Drug Discovery LLC
Most cited
By later US patents
- Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas54US 4,634,465 ACiba-Geigy Corporation · 1987
- Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles51US 3,939,178 AAmerican Home Products Corporation · 1976
- HIV protease inhibitors44US 5,863,950 AAgouron Pharmaceuticals, Inc. · 1999
- HIV protease inhibitors and methods of making the same42US 5,714,518 AAgouron Pharmaceuticals, Inc. · 1998
- Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents39US 4,845,242 AGeorgia Tech Research Corporation · 1989